![Vaccines | Free Full-Text | A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC Vaccines | Free Full-Text | A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC](https://www.mdpi.com/vaccines/vaccines-09-01106/article_deploy/html/images/vaccines-09-01106-g001.png)
Vaccines | Free Full-Text | A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC
![COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00996-y/MediaObjects/41392_2022_996_Fig1_HTML.png)
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
![Frontiers | Diagnostic work-up and phenotypic characteristics of a family with variable severity of distal arthrogryposis type 2B (Sheldon-Hall syndrome) and TNNT3 pathogenic variant Frontiers | Diagnostic work-up and phenotypic characteristics of a family with variable severity of distal arthrogryposis type 2B (Sheldon-Hall syndrome) and TNNT3 pathogenic variant](https://www.frontiersin.org/files/Articles/955041/fgene-13-955041-HTML-r1/image_m/fgene-13-955041-g002.jpg)
Frontiers | Diagnostic work-up and phenotypic characteristics of a family with variable severity of distal arthrogryposis type 2B (Sheldon-Hall syndrome) and TNNT3 pathogenic variant
![mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig1_HTML.png)